The <i>Plasmodium falciparum</i> NCR1 transporter is an antimalarial target that exports cholesterol from the parasite's plasma membrane.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39693420.
- Also identified by DOI 10.1126/sciadv.adq6651 and PMC identifier 11654669.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Malaria, a devastating parasitic infection, is the leading cause of death in many developing countries. Unfortunately, the most deadliest causative agent of malaria, <i>Plasmodium falciparum</i>, has developed resistance to nearly all currently available antimalarial drugs. The <i>P. falciparum</i> Niemann-Pick type C1-related (PfNCR1) transporter has been identified as a druggable target, but its structure and detailed molecular mechanism are not yet available. Here, we present three structures of PfNCR1 with and without the functional inhibitor MMV009108 at resolutions between 2.98 and 3.81 Å using single-particle cryo-electron microscopy (cryo-EM), suggesting that PfNCR1 binds cholesterol and forms a cholesterol transport tunnel to modulate the composition of the parasite plasma membrane. Cholesterol efflux assays show that PfNCR1 is an exporter capable of extruding cholesterol from the membrane. Additionally, the inhibition mechanism of MMV009108 appears to be due to a direct blockage of PfNCR1, preventing this transporter from shuttling cholesterol.
Medical subject headings
- Plasmodium falciparum
- Cholesterol
- Cell Membrane
- Antimalarials
- Protozoan Proteins